Wellesley Investment Advisors »

Travere Therapeutics shares owned by Wellesley Investment Advisors

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Wellesley Investment Advisors from 13F filings

Historical chart of Wellesley Investment Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Wellesley Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $26B 24M 1116.19